Cargando…

Epidemiology of viral respiratory tract infections in an outpatient haematology facility

Viral respiratory tract infections (VRTI) are an important cause of morbidity and mortality in haematology patients, particularly after haematopoietic stem cell transplantation (HSCT). The incidence, clinical presentation and outcome of symptomatic and asymptomatic VRTI in HSCT outpatient unit were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikulska, Małgorzata, Del Bono, Valerio, Gandolfo, Nemo, Dini, Simone, Dominietto, Alida, Di Grazia, Carmen, Bregante, Stefania, Varaldo, Riccardo, Orsi, Andrea, Ansaldi, Filippo, Bacigalupo, Andrea, Viscoli, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079995/
https://www.ncbi.nlm.nih.gov/pubmed/24097084
http://dx.doi.org/10.1007/s00277-013-1912-0
_version_ 1783507936254885888
author Mikulska, Małgorzata
Del Bono, Valerio
Gandolfo, Nemo
Dini, Simone
Dominietto, Alida
Di Grazia, Carmen
Bregante, Stefania
Varaldo, Riccardo
Orsi, Andrea
Ansaldi, Filippo
Bacigalupo, Andrea
Viscoli, Claudio
author_facet Mikulska, Małgorzata
Del Bono, Valerio
Gandolfo, Nemo
Dini, Simone
Dominietto, Alida
Di Grazia, Carmen
Bregante, Stefania
Varaldo, Riccardo
Orsi, Andrea
Ansaldi, Filippo
Bacigalupo, Andrea
Viscoli, Claudio
author_sort Mikulska, Małgorzata
collection PubMed
description Viral respiratory tract infections (VRTI) are an important cause of morbidity and mortality in haematology patients, particularly after haematopoietic stem cell transplantation (HSCT). The incidence, clinical presentation and outcome of symptomatic and asymptomatic VRTI in HSCT outpatient unit were prospectively evaluated during a single influenza season (January–March 2011). Pharyngeal swabs were performed at the first visit and if new symptoms were present. Molecular multiplex assay for 12 respiratory viruses was performed by the regional reference laboratory. Among 264 swabs from 193 outpatients, 58 (22 %) resulted positive for 61 viruses (influenza, n = 20; respiratory syncytial virus [RSV], n = 21; rhinovirus, n = 12; coronavirus, n = 4; adenovirus, n = 3; parainfluenza, n = 1). VRTI were detected more frequently in the presence of symptoms than in asymptomatic patients: 49 out of 162 (30 %) vs. 9 out of 102 (9 %), p < 0.001. Influenza-like illness syndrome (ILI) was significantly associated with a VRTI if compared to other presentations (42 %), while the European Centre for Disease Prevention and Control definition was not (30 %). Positive predictive value (PPV) of ILI for influenza was 17 %. Influenza and RSV peak periods were contemporary. Influenza prophylaxis was given to 25 patients following exposure. Low rate of progression from upper to lower respiratory tract infection (approximately 5 % for influenza and RSV), no nosocomial epidemics and no VRTI-related deaths were observed. VRTI are very frequent in high-risk haematology outpatients, but symptoms are aspecific and PPV of ILI is low. Symptoms of influenza and RSV overlap. Thus, microbiological diagnosis and contact preventive measures are crucial. Rather than universal influenza prophylaxis, prompt diagnosis and treatment of only documented infections could be pursued.
format Online
Article
Text
id pubmed-7079995
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-70799952020-03-23 Epidemiology of viral respiratory tract infections in an outpatient haematology facility Mikulska, Małgorzata Del Bono, Valerio Gandolfo, Nemo Dini, Simone Dominietto, Alida Di Grazia, Carmen Bregante, Stefania Varaldo, Riccardo Orsi, Andrea Ansaldi, Filippo Bacigalupo, Andrea Viscoli, Claudio Ann Hematol Original Article Viral respiratory tract infections (VRTI) are an important cause of morbidity and mortality in haematology patients, particularly after haematopoietic stem cell transplantation (HSCT). The incidence, clinical presentation and outcome of symptomatic and asymptomatic VRTI in HSCT outpatient unit were prospectively evaluated during a single influenza season (January–March 2011). Pharyngeal swabs were performed at the first visit and if new symptoms were present. Molecular multiplex assay for 12 respiratory viruses was performed by the regional reference laboratory. Among 264 swabs from 193 outpatients, 58 (22 %) resulted positive for 61 viruses (influenza, n = 20; respiratory syncytial virus [RSV], n = 21; rhinovirus, n = 12; coronavirus, n = 4; adenovirus, n = 3; parainfluenza, n = 1). VRTI were detected more frequently in the presence of symptoms than in asymptomatic patients: 49 out of 162 (30 %) vs. 9 out of 102 (9 %), p < 0.001. Influenza-like illness syndrome (ILI) was significantly associated with a VRTI if compared to other presentations (42 %), while the European Centre for Disease Prevention and Control definition was not (30 %). Positive predictive value (PPV) of ILI for influenza was 17 %. Influenza and RSV peak periods were contemporary. Influenza prophylaxis was given to 25 patients following exposure. Low rate of progression from upper to lower respiratory tract infection (approximately 5 % for influenza and RSV), no nosocomial epidemics and no VRTI-related deaths were observed. VRTI are very frequent in high-risk haematology outpatients, but symptoms are aspecific and PPV of ILI is low. Symptoms of influenza and RSV overlap. Thus, microbiological diagnosis and contact preventive measures are crucial. Rather than universal influenza prophylaxis, prompt diagnosis and treatment of only documented infections could be pursued. Springer Berlin Heidelberg 2013-10-06 2014 /pmc/articles/PMC7079995/ /pubmed/24097084 http://dx.doi.org/10.1007/s00277-013-1912-0 Text en © Springer-Verlag Berlin Heidelberg 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Mikulska, Małgorzata
Del Bono, Valerio
Gandolfo, Nemo
Dini, Simone
Dominietto, Alida
Di Grazia, Carmen
Bregante, Stefania
Varaldo, Riccardo
Orsi, Andrea
Ansaldi, Filippo
Bacigalupo, Andrea
Viscoli, Claudio
Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title_full Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title_fullStr Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title_full_unstemmed Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title_short Epidemiology of viral respiratory tract infections in an outpatient haematology facility
title_sort epidemiology of viral respiratory tract infections in an outpatient haematology facility
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079995/
https://www.ncbi.nlm.nih.gov/pubmed/24097084
http://dx.doi.org/10.1007/s00277-013-1912-0
work_keys_str_mv AT mikulskamałgorzata epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT delbonovalerio epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT gandolfonemo epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT dinisimone epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT dominiettoalida epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT digraziacarmen epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT bregantestefania epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT varaldoriccardo epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT orsiandrea epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT ansaldifilippo epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT bacigalupoandrea epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility
AT viscoliclaudio epidemiologyofviralrespiratorytractinfectionsinanoutpatienthaematologyfacility